Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Once weekly glucagon-like peptide-1 receptor agonist albiglutide vs. prandial insulin added to basal insulin in patients with type 2 diabetes mellitus : Results over 52 weeks

Leiter, Lawrence A ; Gross, Jorge Luiz ; Chow, Francis C C ; Miller, Diane ; Johnson, Susan L and Ahrén, Bo LU (2017) In Journal of Diabetes and its Complications 31(8). p.1283-1285
Abstract

We have previously reported that once-weekly albiglutide was noninferior to thrice-daily lispro for glycemic lowering, with decreased weight and risk of hypoglycemia, in patients inadequately controlled on basal insulin over 26 weeks. Findings after 52 weeks reveal similar responses to albiglutide as an add-on to insulin glargine.

Please use this url to cite or link to this publication:
author
; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Basal insulin, Clinical trial, Combination therapy, Glucagon-like peptide-1 receptor agonist, Type 2 diabetes
in
Journal of Diabetes and its Complications
volume
31
issue
8
pages
1283 - 1285
publisher
Elsevier
external identifiers
  • pmid:28587789
  • wos:000406081200008
  • scopus:85020115367
ISSN
1056-8727
DOI
10.1016/j.jdiacomp.2017.05.010
language
English
LU publication?
yes
id
068b6333-3237-40d6-a68c-8ddf0f9d5956
date added to LUP
2017-07-03 18:11:00
date last changed
2025-03-17 21:11:50
@article{068b6333-3237-40d6-a68c-8ddf0f9d5956,
  abstract     = {{<p>We have previously reported that once-weekly albiglutide was noninferior to thrice-daily lispro for glycemic lowering, with decreased weight and risk of hypoglycemia, in patients inadequately controlled on basal insulin over 26 weeks. Findings after 52 weeks reveal similar responses to albiglutide as an add-on to insulin glargine.</p>}},
  author       = {{Leiter, Lawrence A and Gross, Jorge Luiz and Chow, Francis C C and Miller, Diane and Johnson, Susan L and Ahrén, Bo}},
  issn         = {{1056-8727}},
  keywords     = {{Basal insulin; Clinical trial; Combination therapy; Glucagon-like peptide-1 receptor agonist; Type 2 diabetes}},
  language     = {{eng}},
  month        = {{03}},
  number       = {{8}},
  pages        = {{1283--1285}},
  publisher    = {{Elsevier}},
  series       = {{Journal of Diabetes and its Complications}},
  title        = {{Once weekly glucagon-like peptide-1 receptor agonist albiglutide vs. prandial insulin added to basal insulin in patients with type 2 diabetes mellitus : Results over 52 weeks}},
  url          = {{http://dx.doi.org/10.1016/j.jdiacomp.2017.05.010}},
  doi          = {{10.1016/j.jdiacomp.2017.05.010}},
  volume       = {{31}},
  year         = {{2017}},
}